Eli Lilly And Co (NYSE:LLY) is set to announce its fourth quarter 2023 financial results next week on Tuesday, 6 February.
The analysts expect Eli Lilly to report $2.19 per share earnings and sales of $8.932 billion, according to data from Benzinga Pro.
Shares are trading on a session volume of 834.501K compared to the average volume (100 days) of 3.126 million.
Thursday, Cantor Fitzgerald reiterated its Overweight rating on Eli Lilly stock and maintained the price target of $630.
Eli Lilly faced renewed scrutiny in January as the FDA inspectors revealed additional manufacturing issues at ...